What the FDA labels say about taking them together
Asenapine and chlorpromazine
Asenapine's FDA label of January 31, 2025 names chlorpromazine in its warnings and precautions section; chlorpromazine's label does not name asenapine itself but warns about its class (Atypical antipsychotics).
Check it at the source: the asenapine FDA label on DailyMed (effective January 31, 2025, Allergan, Inc.); the chlorpromazine FDA label on DailyMed (effective May 12, 2026, Amneal Pharmaceuticals NY LLC).
What does the asenapine label say about chlorpromazine?
Asenapine label, warnings and precautionsThe use of SAPHRIS should be avoided in combination with other drugs known to prolong QTc including Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class 3 antiarrhythmics (e.g., amiodarone, sotalol), antipsychotic medications (e.g., ziprasidone, chlorpromazine, thioridazine), and antibiotics (e.g., gatifloxacin, moxifloxacin).
Source: FDA drug label (Secuado, NDA212268), Noven Therapeutics, LLC, effective January 30, 2025 (SPL set 685eaf44-5944-4f38-afba-0a4fc0b3462b), via openFDA
Source: FDA drug label (SAPHRIS), NDA022117 (Abbvie), as published by Allergan, Inc., effective January 31, 2025 (SPL set 5429f134-839f-4ffc-9944-55f51238def8), via openFDA; the full label on DailyMed
What does the chlorpromazine label say about asenapine?
Chlorpromazine's label does not name asenapine itself; it warns about its class (Atypical antipsychotics):
Chlorpromazine label, boxed warningAnalyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients.
Chlorpromazine label, boxed warningWARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
Source: FDA drug label (CHLORPROMAZINE HYDROCHLORIDE), Amneal Pharmaceuticals NY LLC, effective May 12, 2026 (SPL set aa086a21-de85-4b03-af58-49b70acf8cf0), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Asenapine | Chlorpromazine | |
|---|---|---|
| Labeled for | Schizophrenia, Bipolar disorder | Schizophrenia, Nausea and vomiting |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $2.63 per tablet 10 mg tablet sl | $0.552 per tablet 100 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once